熱門資訊> 正文
RedHill Bizerma重新与纳斯达克合规
2024-09-05 19:18
- RedHill Biopharma (NASDAQ:RDHL) said it has received confirmation from the Nasdaq, stating that the company has regained compliance with the minimum bid price requirement.
- Press Release
More on RedHill
- RedHill shares climb on results indicating potential use of opaganib for obesity-related disorders
- Financial information for RedHill
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。